InGeNA Welcomes the Establishment of Genomics Australia
InGeNA is pleased to welcome the announcement of Genomics Australia, a significant step forward in advancing the integration of genomics into the Australian healthcare system. This initiative lays the foundation for improving health outcomes through the application of genomic technology, particularly in delivering precision healthcare.
The establishment of Genomics Australia aligns with InGeNA’s vision to see genomics mainstreamed into clinical and everyday patient care. However, as genomics transitions from research to implementation, the role of industry is critical in partnership with government to ensure this integration is effective and equitable.
Dr. Erin Evans, CEO of InGeNA, stated:
“InGeNA welcomes the government’s commitment to embedding genomics into clinical care. Industry plays a vital role in this transformation, and we stand ready to partner from the establishment and with Genomics Australia to leverage the strengths of our health system and move at pace. Together, we can ensure the benefits of genomics reach all Australians without delay.”
A Collaborative Vision for Genomics Integration
InGeNA has been instrumental in shaping the national genomics agenda through its Industry Advisory Group to Australian Genomics. This group ensures industry insights guide critical initiatives, fostering effective partnerships between government, research, healthcare, and the private sector.
InGeNA contributed to the foundational efforts for Genomics Australia by participating in the Expert Advisory Group (EAG), consulting on the priorities and functions of this new body. Our partner, Pathology Technology Australia also provided an industry voice to this key body.
Insights to Drive Genomics Forward
InGeNA’s leadership is supported by two seminal reports developed through extensive stakeholder engagement:
These reports provide a roadmap to overcome barriers and unlock the full potential of genomics in healthcare. They emphasize the need for timely action to ensure Australians benefit from genomic advances as other nations race ahead in implementation.
Urgency and Next Steps
While the establishment of Genomics Australia is a promising development, time is of the essence. Australia must act quickly to avoid lagging behind comparable nations in genomics integration.
InGeNA is eager to collaborate on:
- The terms of reference and governance structure for Genomics Australia, including forming an industry expert committee.
- The appointment of a Commissioner to oversee its activities.
- Developing pathways to accelerate implementation and deliver patient benefits without delay.
A Call to Action
The establishment of Genomics Australia represents an opportunity for collaboration between industry, government, research, and healthcare. InGeNA remains committed to providing leadership and expertise to ensure the success of this initiative and deliver real benefits to patients.
Now is the time to act. Together, we can position Australia as a global leader in precision health, ensuring that genomic innovations reach patients quickly and equitably.
Let’s work together to ensure that every day counts in delivering genomic innovation to Australians.
For more information on InGeNA’s contributions and collaborations, explore our reports:
The Minister of the Department of Health and Aged Care media release announcing the establishment of Genomics Australia is available here, for your information.